Cath Lab Digest
VerifiedMagazine
Cath Lab Digest is a monthly news and clinical update for the cardiac catheterization laboratory specialist, focusing on coronary, peripheral vascular (including chronic limb-threatening ischemia), and structural heart disease interventional treatment and care. Source
Actions
Media Outlet details
| Scope | National, Trade/B2B |
|---|---|
| Language | English |
| Country | United States of America |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
| Frequency | Monthly |
Recent Articles
Search ArticlesClient Challenge
JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
AI Disruption in Cardiovascular Devices Accelerates as Investment Surpasses $300 Million and FDA-Cleared Algorithms Top 120 “More than 120 cardiology AI algorithms have received FDA clearance as investment expands across AI-powered ECG analysis, cardiac i
Boston -- Artificial intelligence is fundamentally reshaping the cardiovascular devices landscape, driven by a convergence of clinical urgency, regulatory momentum, and accelerating private capital.
Element Science Expands Executive Leadership Team to Accelerate Commercial Growth and Execution Key leadership hires bring deep medtech scaling expertise to advance the Jewel Patch Wearable Cardioverter Defibrillator
SAN FRANCISCO--Element Science, a pioneering health technology company and creator of the Jewel® Patch Wearable Cardioverter Defibrillator (Patch-WCD) to monitor and protect patients at high-risk of sudden cardiac arrest (SCA), announced several strategic appointments to its executive leadership team. These key hires bring extensive industry experience across commercial strategy, operations, finance, and human resources to drive the company's next phase of growth.
CRF® Announces Late-Breaking Clinical Trials and Science to Be Presented at TCT 2026 Annual Scientific Symposium Takes Place October 31-November 3 in San Diego
TCT 2026 NEW YORK – The Cardiovascular Research Foundation® (CRF®) announced the late-breaking clinical trials and science selected for presentation at TCT® 2026, the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. This year’s conference will take place October 31–November 3 at the San Diego Convention Center bringing together leading investigators, clinicians, and innovators from around the world.
Client Challenge
JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
HMP Global Learning Network
This study investigated the ability of a machine-learning algorithm to detect hypertension and diabetes from facial videos. The algorithm detected hypertension with more than 90% accuracy and diabetes with more than 80% accuracy from 5-second... This study investigated the ability of a machine-learning algorithm to detect hypertension and diabetes from facial videos. The algorithm detected hypertension with more than 90% accuracy and diabetes with more than 80% accuracy from 5-second...
Xylitol May Increase the Risk of Cardiovascular Events
Key takeaways A long-term analysis studied the effects of the artificial sweetener, xylitol, on cardiovascular events in the general population. High blood levels of xylitol were associated with a greater risk of cardiovascular events than lower levels. Further studies on the safety of xylitol and other artificial sweeteners are warranted as they continue to be used in increasing amounts.
AI-Based Diagnosis of Hypertension and Diabetes From a Single Facial Video
Key takeaways This study investigated the ability of a machine-learning algorithm to detect hypertension and diabetes from facial videos. The algorithm detected hypertension with more than 90% accuracy and diabetes with more than 80% accuracy from 5-second videos. If validated, the AI model may serve as a scalable tool to enable wider screening.
Client Challenge
JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.
Radiation Detection Company Introduces Radiant, Expanding Real-Time Radiation Safety for High-Exposure Clinical Environments
GEORGETOWN, TX — Radiation Detection Company (RDC), the world's longest-operating providers of occupational dosimetry services, announced the launch of Radiant real-time dosimetry, a connected electronic dosimetry solution designed to provide clinicians with immediate visibility into radiation levels during high-exposure medical procedures.